Nexgel, Inc. (NXGL) EBITDA Margin (2018 - 2025)
Nexgel's (NXGL) quarterly EBITDA Margin came in at 43.42% in Q4 2025, down 1576.0% YoY from 2.94% in Q4 2024, and down 75.71% on a QoQ basis from 24.71% in Q3 2025.
Nexgel, Inc. (NXGL) EBITDA Margin (2018 - 2025) Analysis & Trends
Nexgel (NXGL) has 8 years of EBITDA Margin data on file, last reported at 43.42% in Q4 2025.
- Quarterly EBITDA Margin fell 1576.0% year-over-year to 43.42% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 29.35% (up 1156.0% YoY) and the FY2025 annual result came in at 29.35%, up 1156.0% from the prior year.
- EBITDA Margin slipped to 43.42% in Q4 2025, from 24.71% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 22.05% in Q2 2025 to a low of 205.05% in Q1 2022.
- A 5-year average of 101.27% and a median of 92.93% in 2024 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2021 — EBITDA Margin surged 50289 bps — and 2025, when it plunged 1576 bps.
- Tracing NXGL's EBITDA Margin over 5 years: stood at 166.42% in 2021, then gained by 10 bps to 149.05% in 2022, then grew by 24 bps to 112.66% in 2023, then jumped by 75 bps to 27.66% in 2024, then tumbled by 57 bps to 43.42% in 2025.
- The last three EBITDA Margin figures came in at 43.42% (Q4 2025), 24.71% (Q3 2025), and 22.05% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -43.42% |
| Sep 30, 2025 | -24.71% |
| Jun 30, 2025 | -22.05% |
| Mar 31, 2025 | -27.69% |
| Dec 31, 2024 | -27.66% |
| Sep 30, 2024 | -26.80% |
| Jun 30, 2024 | -73.19% |
| Mar 31, 2024 | -68.80% |
| Dec 31, 2023 | -112.66% |
| Sep 30, 2023 | -50.12% |
| Jun 30, 2023 | -65.30% |
| Mar 31, 2023 | -142.42% |
| Dec 31, 2022 | -149.05% |
| Sep 30, 2022 | -182.57% |
| Jun 30, 2022 | -127.99% |
| Mar 31, 2022 | -205.05% |
| Dec 31, 2021 | -166.42% |
| Sep 30, 2021 | -182.09% |
| Jun 30, 2021 | -132.61% |
| Mar 31, 2021 | -194.76% |